Related references
Note: Only part of the references are listed.High tumor cell vimentin expression indicatesprolonged survival in patients with ovarian malignant tumors
Sebastian Szubert et al.
GINEKOLOGIA POLSKA (2019)
Circumventing senescence is associated with stem cell properties and metformin sensitivity
Xavier Deschenes-Simard et al.
AGING CELL (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice
Xiao-Hui Zhao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors
Prashanth Rawla et al.
WORLD JOURNAL OF ONCOLOGY (2019)
撤稿声明: CD133+/CD44+/Oct4+/Nestin plus stem-like cells isolated from Panc-1 cell line may contribute to multi-resistance and metastasis of pancreatic cancer (Retraction Article, vol 115, pg 349, 2013) (Retraction of Vol 115, Pg 349, 2013)
Dongqing Wang et al.
ACTA HISTOCHEMICA (2018)
Clinical impact of circulating tumor cells and therapy response in pancreatic cancer (vol 43, pg 1050, 2017)
Keishi Okubo et al.
EJSO (2018)
Liquid Biopsy in Rare Cancers: Lessons from Hemangiopericytoma
Chiara Nicolazzo et al.
ANALYTICAL CELLULAR PATHOLOGY (2018)
Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival
Charles E. Gast et al.
SCIENCE ADVANCES (2018)
Perspective on Cancer Therapeutics Utilizing Analysis of Circulating Tumor Cells
Keun-Yeong Jeong et al.
DIAGNOSTICS (2018)
CTC clusters in cancer progression and metastasis
Anna Fabisiewicz et al.
MEDICAL ONCOLOGY (2017)
Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward
Mohammad Aslam Khan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Filtration-based enrichment of circulating tumor cells from all prostate cancer risk groups
Julius Adebayo Awe et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2017)
Tumacrophage: macrophages transformed into tumor stem-like cells by virulent genetic material from tumor cells
Yizhuang Zhang et al.
ONCOTARGET (2017)
Stromal Expression of Vimentin Predicts the Clinical Outcome of Stage II Colorectal Cancer for High-Risk Patients
Li-guo Liu et al.
MEDICAL SCIENCE MONITOR (2017)
Detection of Circulating Tumour Cells in Urothelial Cancers and Clinical Correlations: Comparison of Two Methods
Emanuela Fina et al.
DISEASE MARKERS (2017)
TAMeless traitors: macrophages in cancer progression and metastasis
Shweta Aras et al.
BRITISH JOURNAL OF CANCER (2017)
Detection of Circulating Tumour Cells and Survival of Patients with Non-small Cell Lung Cancer
Dimple Chudasama et al.
ANTICANCER RESEARCH (2017)
CD44high/ALDH1high head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3-dependent cancer stem cell properties
Sayaka Seino et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2016)
Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma
Katherine E. Poruk et al.
ANNALS OF SURGERY (2016)
Synergistic effects of CD44 and TGF-β1 through AKT/GSK-3β/β-catenin signaling during epithelial-mesenchymal transition in liver cancer cells
Na Ri Park et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer
J. S. Ankeny et al.
BRITISH JOURNAL OF CANCER (2016)
KRAS mutation associated with CD44/CD166 immunoexpression as predictors of worse outcome in metastatic colon cancer
Karen Bento Ribeiro et al.
CANCER BIOMARKERS (2016)
Clinical Significance of Circulating Tumor Microemboli as a Prognostic Marker in Patients with Pancreatic Ductal Adenocarcinoma
Ming-Chu Chang et al.
CLINICAL CHEMISTRY (2016)
Downregulation of vimentin expression increased drug resistance in ovarian cancer cells
Yi Huo et al.
ONCOTARGET (2016)
Pancreatic cancer cell invasion: mesenchymal switch or just hitchhiking?
Remi Samain et al.
TRANSLATIONAL CANCER RESEARCH (2016)
Circulating Tumor Cells Found in Patients With Localized and Advanced Pancreatic Cancer
Birte Kulemann et al.
PANCREAS (2015)
Addressing the challenges of pancreatic cancer: Future directions for improving outcomes
Manuel Hidalgo et al.
PANCREATOLOGY (2015)
VEGF-B promotes cancer metastasis through a VEGF-A-independent mechanism and serves as a marker of poor prognosis for cancer patients
Xiaojuan Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Epithelial-Mesenchymal Transitioned Tumor Cells Capture for Detecting Tumor Progression
Arun Satelli et al.
CLINICAL CANCER RESEARCH (2015)
Circulating tumour cells in metastatic head and neck cancers
Arutha Kulasinghe et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Circulating Tumor Cells as a Biomarker of Response to Treatment in Patient-Derived Xenograft Mouse Models of Pancreatic Adenocarcinoma
Robert J. Torphy et al.
PLOS ONE (2014)
Circulating tumor cells: Advances in isolation and analysis, and challenges for clinical applications
Ramdane Harouaka et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis
Lu Han et al.
TUMOR BIOLOGY (2014)
Usefulness of Circulating Tumor Cell Detection in Pancreatic Adenocarcinoma Diagnosis
Isabelle Iwanicki-Caron et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Enhancement of the Antiproliferative Activity of Gemcitabine by Modulation of c-Met Pathway in Pancreatic Cancer
Amir Avan et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling
Altaf Mohammed et al.
TRANSLATIONAL ONCOLOGY (2013)
Pancreatic cancer circulating tumour cells express a cell motility gene signature that predicts survival after surgery
Gregory Sergeant et al.
BMC CANCER (2012)
A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker
L. Khoja et al.
BRITISH JOURNAL OF CANCER (2012)
Cancer stem cells: an evolving concept
Long V. Nguyen et al.
NATURE REVIEWS CANCER (2012)
Vimentin in cancer and its potential as a molecular target for cancer therapy
Arun Satelli et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Gemcitabine Plus nab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
Daniel D. Von Hoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Epidermal Growth Factor Receptor in Pancreatic Cancer
Melissa Oliveira-Cunha et al.
Cancers (2011)
ALCAM Is Associated With Chemoresistance and Tumor Cell Adhesion in Pancreatic Cancer
Xin Hong et al.
JOURNAL OF SURGICAL ONCOLOGY (2010)
Pancreatic Cancer
Manuel Hidalgo
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Suppressive Effects of Vascular Endothelial Growth Factor-B on Tumor Growth in a Mouse Model of Pancreatic Neuroendocrine Tumorigenesis
Imke Albrecht et al.
PLOS ONE (2010)
Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse
C. Kahlert et al.
BRITISH JOURNAL OF CANCER (2009)
CD44 and EpCAM: Cancer-Initiating Cell Markers
Rachid Marhaba et al.
CURRENT MOLECULAR MEDICINE (2008)
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Sunitha Nagrath et al.
NATURE (2007)
Development and characterization of gemcitabine-resistant pancreatic tumor cells
Ami N. Shah et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Share Paper
